{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T09:53:44Z","timestamp":1785664424922,"version":"3.56.0"},"reference-count":18,"publisher":"Sociedade Brasileira de Pneumologia e Tisiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bras Pneumol."],"abstract":"<jats:p>Objective: To evaluate tuberculosis diagnosis with the use of the lateral flow urine lipoarabinomannan assay (LF-LAM) in addition to the Xpert\u00ae MTB\/RIF Ultra assay on sputum in HIV-positive inpatients and outpatients. Methods: This was a prospective cross-sectional study including HIV-positive patients = 18 years of age with an indication for LF-LAM in accordance with Brazilian National Ministry of Health criteria. Results: A total of 140 patients were included in the study. LF-LAM was positive in 23 (16.4%). An additional 12 (8.6%) were diagnosed with the aid of LF-LAM, this increase in tuberculosis detection being statistically significant. LF-LAM-positive patients were younger and had lower CD4 counts in comparison with LF-LAM-negative patients. Smoking was more common among LF-LAM-negative patients than among LF-LAM-positive patients. Conclusions: The use of LF-LAM significantly increases the detection of tuberculosis in HIV-positive patients, mostly in those who are hospitalized. These findings highlight the utility of LF-LAM, especially in regions with high tuberculosis and HIV infection incidence.<\/jats:p>","DOI":"10.36416\/1806-3756\/e20250152","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T22:31:10Z","timestamp":1752705070000},"page":"e20250152","source":"Crossref","is-referenced-by-count":2,"title":["Lateral flow urine lipoarabinomannan assay for tuberculosis diagnosis in HIV-positive inpatients and outpatients"],"prefix":"10.36416","author":[{"given":"Giovana","family":"Rodrigues Pereira1,2","sequence":"first","affiliation":[{"name":"1. Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias Pneumol\u00f3gicas, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul - UFRGS - Porto Alegre (RS) Brasil. 2. Laborat\u00f3rio Municipal de Alvorada, Alvorada (RS) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcia","family":"Silva Barbosa2","sequence":"additional","affiliation":[{"name":"2. Laborat\u00f3rio Municipal de Alvorada, Alvorada (RS) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Secchi2","sequence":"additional","affiliation":[{"name":"2. Laborat\u00f3rio Municipal de Alvorada, Alvorada (RS) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiara","family":"Priscila dos Passos2","sequence":"additional","affiliation":[{"name":"2. Laborat\u00f3rio Municipal de Alvorada, Alvorada (RS) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Kulzer Santos3","sequence":"additional","affiliation":[{"name":"3. Faculdade de Medicina, Universidade Federal do Rio Grande do Sul - UFRGS - Porto Alegre (RS) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimunda","family":"Sinthia Lima de Braga3","sequence":"additional","affiliation":[{"name":"3. Faculdade de Medicina, Universidade Federal do Rio Grande do Sul - UFRGS - Porto Alegre (RS) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Scheffer de Souza3","sequence":"additional","affiliation":[{"name":"3. Faculdade de Medicina, Universidade Federal do Rio Grande do Sul - UFRGS - Porto Alegre (RS) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gean","family":"Souza Ramos3","sequence":"additional","affiliation":[{"name":"3. Faculdade de Medicina, Universidade Federal do Rio Grande do Sul - UFRGS - Porto Alegre (RS) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Vitor Vigne Duz3","sequence":"additional","affiliation":[{"name":"3. Faculdade de Medicina, Universidade Federal do Rio Grande do Sul - UFRGS - Porto Alegre (RS) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Rossato Silva1,3,4","sequence":"additional","affiliation":[{"name":"1. Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias Pneumol\u00f3gicas, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul - UFRGS - Porto Alegre (RS) Brasil. 3. Faculdade de Medicina, Universidade Federal do Rio Grande do Sul - UFRGS - Porto Alegre (RS) Brasil. 4. Servi\u00e7o de Pneumologia, Hospital de Cl\u00ednicas de Porto Alegre - HCPA - Porto Alegre (RS) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22288","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"ref0","unstructured":"1.           World Health Organization (WHO) [homepage on the Internet]. Geneva: WHO; c2024 [updated 2024 Oct 29; cited 2024 Nov 1]. Global Tuberculosis Report 2024. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/379339\/9789240101531-eng.pdf?sequence=1"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2.           Hunter SW, Gaylord H, Brennan PJ. Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli. J Biol Chem. 1986;261(26):12345-12351. https:\/\/doi.org\/10.1016\/S0021-9258(18)67246-1","DOI":"10.1016\/s0021-9258(18)67246-1"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3.           Peter J, Green C, Hoelscher M, Mwaba P, Zumla A, Dheda K. Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments. Curr Opin Pulm Med. 2010;16(3):262. https:\/\/doi.org\/10.1097\/MCP.0b013e328337f23a","DOI":"10.1097\/mcp.0b013e328337f23a"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4.           Sarkar P, Biswas D, Sindhwani G, Rawat J, Kotwal A, Kakati B. Application of lipoarabinomannan antigen in tuberculosis diagnostics: current evidence. Postgrad Med J. 2014;90(1061):155-63. https:\/\/doi.org\/10.1136\/postgradmedj-2013-132053","DOI":"10.1136\/postgradmedj-2013-132053"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5.           Pereira Arias-Bouda LM, Nguyen LN, Ho LM, Kuijper S, Jansen HM, Kolk AHJ. Development of antigen detection assay for diagnosis of tuberculosis using sputum samples. J Clin Microbiol. 2000;38(6):2278-83. https:\/\/doi.org\/10.1128\/JCM.38.6.2278-2283.2000","DOI":"10.1128\/jcm.38.6.2278-2283.2000"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6.           Crawford AC, Laurentius LB, Mulvihill TS, Granger JH, Spencer JS, Chatterjee D, et al. Detection of the tuberculosis antigenic marker mannose-capped lipoarabinomannan in pretreated serum by surface-enhanced Raman scattering. Analyst. 2016;142(1):186-96. https:\/\/doi.org\/10.1039\/C6AN02110G","DOI":"10.1039\/c6an02110g"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7.           Shah M, Hanrahan C, Wang ZY, Dendukuri N, Lawn SD, Denkinger CM, et al. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults. Cochrane database Syst Rev. 2016;2016(5):CD011420. https:\/\/doi.org\/10.1002\/14651858.CD011420.pub2","DOI":"10.1002\/14651858.cd011420.pub2"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8.           Bulterys MA, Wagner B, Redard-Jacot M, Suresh A, Pollock NR, Moreau E, et al. Point-Of-Care Urine LAM Tests for Tuberculosis Diagnosis: A Status Update. J Clin Med. 2019;9(1):111 https:\/\/doi.org\/10.3390\/jcm9010111","DOI":"10.3390\/jcm9010111"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9.           Flores J, Cancino JC, Chavez-Galan L. Lipoarabinomannan as a Point-of-Care Assay for Diagnosis of Tuberculosis: How Far Are We to Use It? Front Microbiol. 2021;12:638047. https:\/\/doi.org\/10.3389\/fmicb.2021.638047","DOI":"10.3389\/fmicb.2021.638047"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10.        Bjerrum S, Schiller I, Dendukuri N, Kohli M, Nathavitharana RR, Zwerling AA, et al. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV. Cochrane Database Syst Rev. 2019;2019(10):CD011420. https:\/\/doi.org\/10.1002\/14651858.CD011420.pub3","DOI":"10.1002\/14651858.cd011420.pub3"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11.        World Health Organization (WHO) [homepage on the Internet]. Geneva: WHO. WHO operational handbook on tuberculosis. Module 2: screening-systematic screening for tuberculosis disease. 2021. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240022614","DOI":"10.2471\/b09403"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12.        Tsere DB, Shirima GM, Grundy BS, Heysell SK, Mpagama SG, Mziray SR, et al. Multiple pathogens contribute to human immunodeficiency virus-related sepsis in addition to Mycobacterium tuberculosis: A prospective cohort in Tanzania. Int J Mycobacteriol. 2022;11(3):241-248. https:\/\/doi.org\/10.4103\/ijmy.ijmy_80_22","DOI":"10.4103\/ijmy.ijmy_80_22"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13.        Byashalira K, Mbelele P, Semvua H, Chilongola J, Semvua S, Liyoyo A, et al. Clinical outcomes of new algorithm for diagnosis and treatment of Tuberculosis sepsis in HIV patients. Int J Mycobacteriol. 2019;8(4):313-9. https:\/\/doi.org\/10.4103\/ijmy.ijmy_135_19","DOI":"10.4103\/ijmy.ijmy_135_19"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14.        Barr DA, Lewis JM, Feasey N, Schutz C, Kerkhoff AD, Jacob ST, et al. Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient data. Lancet Infect Dis. 2020;20(6):742-52. https:\/\/doi.org\/10.1016\/S1473-3099(19)30695-4","DOI":"10.1016\/s1473-3099(19)30695-4"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15.        Peter JG, Zijenah LS, Chanda D, Clowes P, Lesosky M, Gina P, et al. Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: A pragmatic, parallel-group, multicountry, open-label, randomised controlled trial. Lancet. 2016;387(10024):1187-97. https:\/\/doi.org\/10.1016\/S0140-6736(15)01092-2","DOI":"10.1016\/s0140-6736(15)01092-2"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16.        Gupta-Wright A, Corbett EL, van Oosterhout JJ, Wilson D, Grint D, Alufandika-Moyo M, et al. Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial. Lancet. 2018;392(10144):292-301. https:\/\/doi.org\/10.1016\/S0140-6736(18)31267-4","DOI":"10.1016\/s0140-6736(18)31267-4"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17.        World Health Organization (WHO) [homepage on the Internet]. Geneva: WHO. Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV, 2019. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241550604","DOI":"10.1016\/j.jval.2020.04.604"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18.        Huerga H, Mathabire Rucker SC, Bastard M, Mpunga J, Amoros Quiles I, Kabaghe C, et al. Urine Lipoarabinomannan Testing for All HIV Patients Hospitalized in Medical Wards Identifies a Large Proportion of Patients with Tuberculosis at Risk of Death. Open Forum Infect Dis. 2021;8(2):ofaa639. https:\/\/doi.org\/10.1093\/ofid\/ofaa639","DOI":"10.1093\/ofid\/ofaa639"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T22:31:12Z","timestamp":1752705072000},"score":1,"resource":{"primary":{"URL":"https:\/\/jornaldepneumologia.com.br\/details\/4135\/en-US"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":18,"URL":"https:\/\/doi.org\/10.36416\/1806-3756\/e20250152","relation":{},"ISSN":["1806-3756"],"issn-type":[{"value":"1806-3756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]}}}